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Abstract
Background More than 2 years have passed since the
proposal of the diagnostic criteria for IgG4-related kidney
disease (IgG4-RKD). The aim of this study was to estimate
the number of histological diagnosis for IgG4-RKD
throughout Japan and to clarify the regional distribution of
the development of this disease.
Methods A questionnaire was supplied to 140 research
facilities registered in the Japan Renal Biopsy Registry (J-
RBR). The items of the questionnaire were the total
number of renal biopsies performed and the number of
cases diagnosed as IgG4-RKD in 2012 and 2013 at each
facility. Age, sex, and diagnosis category were also
included for the IgG4-RKD cases. The geographic distri-
bution of the disease development was evaluated using
clinical case reports presented at the Eastern/Western
regional meeting of the Japanese Society of Nephrology
during the 15 years following 2001.
Results Forty-seven facilities completed the question-
naire, resulting in a collection rate of 34 %. The total
numbers of renal biopsies in 2012 and 2013 were 3387 and
3591, respectively. Forty-seven of these cases (24 in 2012
and 23 in 2013) were diagnosed as IgG4-RKD. The fre-
quency of development of IgG4-RKD per one million over
40-year-old individuals during these 15 years varied
between 0.9 and 3.1, depending on Japanese geographic
region of Japan.
Conclusion The results of the present survey indicate that
the number of diagnosis for IgG4-RKD is approximately
130 cases per year throughout Japan, and no regional dif-
ferences in disease frequency appear to exist.
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Introduction
The accumulation of clinical cases with extra-pancreatic
lesions associated with autoimmune pancreatitis (AIP) led
to the establishment of IgG4-related disease (IgG4-RD) as
a new clinical disease. Although the renal disorder was first
described in relation to AIP, it is now considered to be a
characteristic condition within the category of IgG4-RD [1,
2]. In fact, the number of case reports for tubulointerstitial
nephritis associated with IgG4-RD presented at the East-
ern/Western regional meeting of the Japanese Society of
Nephrology (JSN) has gradually increased since 2001
(Fig. 1). Therefore, the ‘‘IgG4-related Kidney Disease’’
Working Group (IgG4-RKD WG) was assembled under the
JSN’s Committee for Standardized Pathological Kidney
Diagnosis and proposed diagnostic criteria and an algo-
rithm for the diagnosis of IgG4-RKD in 2011 [3]. The
diagnostic criteria are based on clinical and serological
features, imaging features, histology, and other organ
involvements. Histology, including immunostaining, is the
most important item, and a definite diagnosis cannot be
established without appropriate histological findings in the
kidney or other organs. The diagnosis is classified into
three categories: definite, probable, and possible.
More than 4 years have passed since the WG proposed
the diagnostic criteria for IgG4-RKD, and, with the
approval of the ethical board of the JSN (approval number:
7), the WG has performed a multi-center retrospective
study of clinicopathological features of IgG4-RKD. The
present study aimed to determine how frequently the
diagnosis of IgG4-RKD was made throughout Japan. To
address this question, we designed a brief online frequency
questionnaire to be administered to Japanese nephrologists.
Materials and methods
The questionnaire was supplied to 140 research facilities
registered as secondary facilities in the Japan Renal Biopsy
Registry (J-RBR), which is a nationwide, web-based,
prospective registry system designed to record pathologi-
cal, clinical, and laboratory data about renal biopsies per-
formed in Japan [4]. The questionnaire items included
assessments of the total number of renal biopsies and the
number of cases diagnosed as IgG4-RKD in 2013 and 2014
at each facility. Hereafter, we call this data the ‘‘2-year
material.’’ The protocol for this study was approved by the
ethics committee of Fukuoka University Hospital in
accordance with the guideline on epidemiological research
from Japan’s Ministry of Health, Labor, and Welfare (ap-
proval number: 15-1-16). In addition to the questionnaire
administration, age, sex, and diagnosis category were
sampled from the case reports presented at the JSN’s
Eastern/Western regional meeting in the 15 years follow-
ing 2001. Hereafter, we call this data the ‘‘15-year mate-
rial.’’ Furthermore, to determine the geographic
distribution of the development of IgG4-RKD in Japan, we
calculated the numbers of IgG4-RKD cases from every
region of Japan using these two types of materials. Every
prefecture population data was referred to ‘‘Population by
five-year age group and prefecture’’ in Japan statistical
yearbook 2013 offered by Statics Japan (http://www.stat.
go.jp/).
Continuous variables are shown as mean values ± s-
tandard deviation (SD). Quantitative variables were com-
pared using Student’s t test or Chi square test. The
frequency of IgG4-RKD in the 15-year material among the
different regions was compared using one-way analysis of
variance (ANOVA) and Kruskal–Wallis test. p values
of\ 0.05 (obtained by two-tailed testing) were considered
to indicate statistical significance.
Results
A total of 47 nephrologists (44 physicians and 3 pediatri-
cians) affiliated with J-RBR-registered facilities completed
the questionnaire (collection rate: 34 %). The total num-
bers of renal biopsies performed in these facilities in 2012
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Fig. 1 The distribution of clinical case reports for IgG4-related
kidney disease presented at the Eastern/Western regional meeting of
the JSN during the recent 15 years
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and 2013 were 3387 and 3591, respectively. Among these
patients, 47 (24 in 2012 and 23 in 2013) were diagnosed
with IgG4-RKD. This resulted in a rate of 6.7 IgG4-RKD
cases per 1000 renal biopsies. Patient informations of age,
sex, and diagnosis category were obtained besides one
patient. The ages of the 46 patients ranged from 38 to
81 years, and the average and median values were
66.8 ± 9.3 and 67.5 years, respectively. The ratio of men
to women was 44:2 (Fig. 2a). Thirty-five diagnoses were
categorized as definite (76.1 %), 4 as probable (8.7 %), 6
as possible (13 %), and 1 as unknown.
One hundred fifty-eight clinical cases that may have
corresponded to IgG4-RKD were sampled from the 15-year
material. The numbers of cases reported in the Eastern and
Western regional meetings appeared to be comparable
(Fig. 1). The ages of the patients ranged from 25 to
86 years, and the average and median values were
66.9 ± 10.4 and 68.0 years, respectively. The ratio of male
to female patients was 128:30 (Fig. 2b). There was a sig-
nificant sex difference for the development of IgG4-RKD,
and the average ages also differed significantly between
males and females (68.4 ± 9.2 vs 60.4 ± 12.9 years). One
hundred-twenty diagnoses were categorized as definite
(76.0 %), 13 as probable (8.2 %), and 25 as possible
(15.8 %). These category proportions were almost equal to
those obtained from the 2-year material.
To determine the geographic distribution of the devel-
opment of this disease in Japan, every case was assigned to
a certain region based on the location of the corresponding
hospital. The diagnosis frequencies per thousand renal
biopsies using the 2-year material and the development
frequencies per one million over 40-year-old individuals
using the 15-year material were calculated in every district
of Japan. Two cases younger than 40-year-old were
excluded in this analysis to compare with the middle-age
and elderly population size and the total number of cases
was 156 in Table 1. For the histological diagnosis fre-
quency in 2-year material the number of cases was not
enough to evaluate the significant difference among dis-
tricts. Concerning the development frequency in 15-year
material the maximal frequency of 3.1 was obtained in the
Hokuriku-Koshinetsu region, and the minimal frequency of
0.9 in the Tohoku regions. When the data were examined
using One-way ANOVA and Kruskal–Wallis test, how-
ever, there were no significant differences among the fre-
quencies of these areas (p = 0.72).
Discussion
IgG4-RD is characterized by consistent pathological fea-
tures, including tumefactive lesions and dense lympho-
plasmacytic infiltrate rich in IgG4-positive plasma cells
with fibrosis across a wide range of organ systems [1, 2].
IgG4-RD was first designated in Japan, and comprehensive
diagnostic criteria were established, in 2012 [5]. Despite
insufficient epidemiologic research, Umehara et al. esti-
mated that 2.8–10.8/million population/year, with
336–1300 patients are newly diagnosed per year through-
out Japan based on the numbers of visiting patients of two
university hospitals in the Ishikawa prefecture [1]. In our
daily medical practice, patients with IgG4-RKD are
encountered significantly less often than those with IgG4-
related dacryoadenitis and sialadenitis, which is represen-
tative of IgG4-RD. According to the results of the 2-year
material, the histological diagnosis frequency for IgG4-
RKD was 0.67 % of the total biopsied cases in 47 J-RBR-
registered facilities. With regard to the number of native
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renal biopsies performed in Japan per year, the Research
Group on Progressive Renal Disease from Japan’s Ministry
of Health, Labor, and Welfare recently determined, using a
questionnaire, that biopsies were performed in
17,000–21,000 and 20,000–22,000 cases in 2012 and 2013,
respectively [6]. From these data, the number of histolog-
ical diagnosis for IgG4-RKD can be roughly estimated to
be 130 (114–147) cases per year throughout Japan. Most
patients with IgG4-RKD have IgG4-related extra-renal
lesions, with salivary glands, lacrimal glands, lymph nodes,
and the pancreas being most frequently affected [3, 7–10].
According to diagnostic criteria, in the case of the quali-
fying requirement for histologic findings in extra-renal
organs, characteristic renal radiologic findings were rec-
ommended to diagnose IgG4-RKD despite unperformed
renal biopsies. Meanwhile in this study, the objects
were biopsied cases and such particular cases were not
included. Therefore, the obtained the number might be
underestimated.
It was reported that IgG4-RKD is strikingly more pre-
dominant in men, and average patient age is about 65 years
[3, 7–10]. The results of the 2-year material also indicated
that elderly men were predominantly affected; thus, the
average age was 66.8 ± 9.3 years, and 95 % of the
patients newly diagnosed within 2 years were male.
Although 2-year material and 15-year material were con-
stituted with extremely rough data, these characteristics
were the same as those obtained from the 15-year material.
These numbers are apparently higher than those for other
types of IgG4-RD, such as autoimmune pancreatitis [11]
and IgG4-related dacryoadenitis and sialadenitis [12].
Although rapidly progressive glomerulonephritis (RPGN)
also affects the elderly, its sex ratio is apparently different
from that of IgG4-RKD. It was reported the ratio of male
was 40.9 % of the RPGN patients diagnosed between 2002
and 2007 by the RPGN Registry Group [13]. According to
the recently reported results of a questionnaire by the
Research Group on Progressive Renal Disease from
Japan’s Ministry of Health, Labor, and Welfare, the num-
bers of new patients with biopsy-proven RPGN in 2013
was 514, which corresponds to 5.4 % of the total cases
with renal biopsy in medical training facilities authorized
by the JSN [6]. The diagnosis of RPGN was supported by
biopsy in 55.4 % of the patients, and the incidence of
RPGN in 2013 throughout Japan was estimated to be
2100–2400. Renal amyloidosis is also an elderly onset
renal disease. According to the data registered with the
J-RBR from July 2007 to 2010, the development frequency
of renal amyloidosis was 1.5 % of all biopsied cases (137/
9439) [4, 14]. The frequency of these diseases increased
together with age, 3.9 % in the case of those 60-year- old
and older and 7.2 % in the cases of those 80-year-old and
older [15]. Therefore, the number of histological diagnosis
for IgG4-RKD is less than one-tenth that of RPGN, and
less than one-half that of renal amyloidosis. General
nephrologists seem to accept the practicality of these ratios.
The geographical distribution of the development of
IgG4-RKD was evaluated using both ‘‘2-year’’ and ‘‘15-
year’’ materials (Table 1). In 2-year material the numbers
of cases in each district were so small that un-meaningful
examination with the expectancy less than 5 was per-
formed. Then every case was re-assigned to Eastern or
Western Japan and Chi square test between them was
performed. Finally it was revealed that there was no sig-
nificant difference in diagnosis frequency between them.
While for development frequency in 15-year material, the
frequency in the Hokuriku-Koshinetsu region was 3.1 cases
per one million over 40-year-old individuals, which is the
largest value seen in Japan. Many researchers who have
been interested in IgG4-RD since early stage are located in
Table 1 Regional variation in
the development of IgG4-RKD
District 2-year material 15-year material
Cases Total biopsies A Cases Population C40 years old 9103 B
Hokkaido 3 197 15.2 6 3387 1.8
Tohoku 10 1246 8.0 5 5642 0.9
Kanto 4 1063 3.8 61 24,937 2.4
Hokuriku-Koshinetsu 13 860 15.1 16 5132 3.1
Tokai 3 1304 2.3 13 8796 1.5
Kinki 7 532 13.2 27 12,332 2.2
Chugoku 2 628 3.2 8 4549 1.8
Shikoku 2 414 4.8 5 2442 2.0
Kyushu-Okinawa 3 734 4.1 15 8606 1.7
Total 47 6978 6.7 156 75,823 2.1
A The diagnosis frequencies per thousand renal biopsies, B The development frequencies per million
among older than 40-year-old individuals
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this region, and their highly accurate diagnoses might have
contributed to this high frequency. Nevertheless, we found
no significant differences among the numbers of regional
variations in the development of IgG4-RKD. In this study
both materials were rough and not available for close
examination to reveal the significant differences, but
showed that IgG4-RKD is found throughout Japan. Precise
regional difference remains to be studied.
Conclusions
In summary, although IgG4-RKD was recently recognized
as a clinical entity, and applicable diagnostic criteria and an
algorithm were proposed in 2011, epidemiological data are
still insufficient. Based on the J-RBR questionnaire utilized
in the present study, the number of histological diagnosis of
IgG4-RKD in Japan is estimated to be approximately 130
cases per year. There was no significant difference in
diagnosis frequency per thousand renal biopsies between
Eastern and Western Japan. In addition, the evaluation of
available clinical cases reported within the past 15 years
shows no regional variations in the development of this
disease. Accordingly, we should pay attention to IgG4-
RKD as one of the important kidney disease in the elderly
distributed all over Japan.
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Appendix
The following facilities responded to the questionnaire:
Hokkaido District
• Asahikawa Medical University Hospital (Division of
Cardiology, Nephrology, Pulmonology, and Neurology,
Department of Internal Medicine)
• Hokkaido University Graduate School of Medicine
(Department of Medicine II)
• Hokkaido University Graduate School of Medicine
(Department of Pediatrics).
Tohoku District
• Iwate Prefectural Central Hospital (Department of
Nephrology)
• Japan Community Healthcare Organization, Sendai
Hospital (Department of Nephrology)
• Tohoku University Hospital and affiliated hospitals
(Department of Nephrology, Endocrinology, and
Hypertension)
• Yamagata University School of Medicine (Department
of Cardiology, Pulmonology, and Nephrology).
Kanto District
• Dokkyo Medical University Koshigaya Hospital
(Department of Nephrology)
• National Center for Child Health and Development
(Department of Nephrology and Rheumatology)
• Saitama Medical University, Saitama Medical Center
(Department of Nephrology and Hypertension)
• Showa University Fujigaoka Hospital (Division of
Nephrology)
• St. Marianna University School of Medicine (Division
of Nephrology and Hypertension, Department of Inter-
nal Medicine)
• Tokyo Metropolitan Children’s Medical Center
(Department of Nephrology)
• University of Tsukuba, Faculty of Medicine (Depart-
ment of Nephrology).
Hokuriku-Koshinetsu District
• Nagaoka Red Cross Hospital (Department of Internal
Medicine)
• Kanazawa Medical University School of Medicine
(Division of Nephrology)
• Kanazawa University Hospital (Division of Rheuma-
tology, Department of Internal Medicine)
• Niigata University Graduate School of Medical and
Dental Sciences (Division of Clinical Nephrology and
Rheumatology)
• Public Central Hospital of Matto-Ishikawa
• Shinshu University School of Medicine (Division of
Nephrology)
• Toyama City Hospital (Department of Nephrology)
• Toyama Prefectural Central Hospital (Department of
Internal Medicine)
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• University of Fukui, Faculty of Medical Sciences
(Division of Nephrology).
Tokai District
• Nagoya University Hospital (Department of
Nephrology)
• Japan Community Healthcare Organization, Yokkaichi
Hazu Medical Center (Department of Nephrology and
Dialysis)
• Nagoya Kyoritsu Hospital (Department of Internal
Medicine)
• Shizuoka General Hospital (Department of
Nephrology).
Kinki District
• Kitano Hospital, the Tazukekofukai Medical Research
Institute (Division of Nephrology and Dialysis)
• Kobe University Graduate School of Medicine (Divi-
sion of Nephrology and Kidney Center)
• Kyoto Prefectural University School of Medicine
(Division of Nephrology, Department of Medicine)
• National Cerebral and Cardiovascular Center (Division
of Hypertension and Nephrology)
• Osaka University Graduate School of Medicine
(Department of Geriatric Medicine and Nephrology)
• Wakayama Medical University (Department of
Pediatrics).
Chugoku District
• Hiroshima University Hospital (Department of
Nephrology)
• Kurashiki Central Hospital (Division of Nephrology)
• Mizushima Kyodo Hospital (Department of Internal
Medicine)
• Okayama University Graduate School of Medicine,
Dentistry, and Pharmaceutical Sciences (Department of
Medicine and Clinical Science).
Shikoku District
• Kagawa University, Faculty of Medicine (Department
of Cardiorenal and Cerebrovascular Medicine)
• Kochi University, Kochi Medical School (Department
of Endocrinology, Metabolism, and Nephrology)
• Kochi University, Kochi Medical School (Department
of Pediatrics)
• The University of Tokushima, Graduate School of
Medicine (Department of Nephrology).
Kyushu District
• Fukuoka University School of Medicine (Division of
Nephrology and Rheumatology, Department of Internal
Medicine)
• Japanese Red Cross Fukuoka Hospital (Nephrology and
Dialysis Center)
• Japanese Red Cross Fukuoka Hospital (Department of
Pediatrics)
• Nagasaki University Hospital (Second Department of
Internal Medicine)
• Saga University, Faculty of Medicine (Department of
Cardiovascular and Renal Medicine)
• University of Occupational and Environmental Health
(Second Department of Internal Medicine).
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